<code id='17C41486F9'></code><style id='17C41486F9'></style>
    • <acronym id='17C41486F9'></acronym>
      <center id='17C41486F9'><center id='17C41486F9'><tfoot id='17C41486F9'></tfoot></center><abbr id='17C41486F9'><dir id='17C41486F9'><tfoot id='17C41486F9'></tfoot><noframes id='17C41486F9'>

    • <optgroup id='17C41486F9'><strike id='17C41486F9'><sup id='17C41486F9'></sup></strike><code id='17C41486F9'></code></optgroup>
        1. <b id='17C41486F9'><label id='17C41486F9'><select id='17C41486F9'><dt id='17C41486F9'><span id='17C41486F9'></span></dt></select></label></b><u id='17C41486F9'></u>
          <i id='17C41486F9'><strike id='17C41486F9'><tt id='17C41486F9'><pre id='17C41486F9'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:12
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          How AI helped researchers track recovery from depression
          How AI helped researchers track recovery from depression

          AdobeResearcherssaythey’vebeenabletomeasurerecoveryfromtreatment-resistantdepressionthroughbrainscan

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

          2:58FormerPresidentandRepublicanpresidentialcandidateDonaldTrumpreactsasheholdsacampaignrallyinErie,